EN
詢價車

化學材料

(11aS)-(-)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-bis[(R)-1-phenylethyl]amine, min. 98% (S)-SIPHOS-PE

(11aS)-(-)-10,11,12,13-Tetrahydrodiindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-bis[(R)-1-phenylethyl]amine, min. 98% (S)-SIPHOS-PE

15-5163 / 100mg
CAS：500997-70-6
加入洽詢
racemic-8,8'-Bis(diphenylphosphino)-3,3',4,4'-tetrahydro-4,4,4',4',6,6'-hexamethyl-2,2'-spirobi[2H-1-benzopyran], min. 95% SPANphos

racemic-8,8'-Bis(diphenylphosphino)-3,3',4,4'-tetrahydro-4,4,4',4',6,6'-hexamethyl-2,2'-spirobi[2H-1-benzopyran], min. 95% SPANphos

15-5165 / 500mg
CAS：556797-94-5
加入洽詢
racemic-8,8'-Bis(diphenylphosphino)-3,3',4,4'-tetrahydro-4,4,4',4',6,6'-hexamethyl-2,2'-spirobi[2H-1-benzopyran], min. 95% SPANphos

racemic-8,8'-Bis(diphenylphosphino)-3,3',4,4'-tetrahydro-4,4,4',4',6,6'-hexamethyl-2,2'-spirobi[2H-1-benzopyran], min. 95% SPANphos

15-5165 / 100mg
CAS：556797-94-5
加入洽詢
(R)-(+)-7-Bis(3,5-di-t-butylphenyl)phosphino-7'-[(pyridine-2-ylmethyl)amino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 98% (>99% ee) (R)-DTB-SpiroPAP

(R)-(+)-7-Bis(3,5-di-t-butylphenyl)phosphino-7'-[(pyridine-2-ylmethyl)amino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 98% (>99% ee) (R)-DTB-SpiroPAP

15-5166 / 100mg
CAS：1298133-21-7
加入洽詢
(R)-(+)-7-Bis(3,5-di-t-butylphenyl)phosphino-7'-[(pyridine-2-ylmethyl)amino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 98% (>99% ee) (R)-DTB-SpiroPAP

(R)-(+)-7-Bis(3,5-di-t-butylphenyl)phosphino-7'-[(pyridine-2-ylmethyl)amino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 98% (>99% ee) (R)-DTB-SpiroPAP

15-5166 / 25mg
CAS：1298133-21-7
加入洽詢
(S)-(-)-7-Bis(3,5-di-t-butylphenyl)phosphino-7'-[(pyridine-2-ylmethyl)amino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 98% (>99% ee) (S)-DTB-SpiroPAP

(S)-(-)-7-Bis(3,5-di-t-butylphenyl)phosphino-7'-[(pyridine-2-ylmethyl)amino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 98% (>99% ee) (S)-DTB-SpiroPAP

15-5167 / 100mg
CAS：1415636-82-6
加入洽詢
(S)-(-)-7-Bis(3,5-di-t-butylphenyl)phosphino-7'-[(pyridine-2-ylmethyl)amino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 98% (>99% ee) (S)-DTB-SpiroPAP

(S)-(-)-7-Bis(3,5-di-t-butylphenyl)phosphino-7'-[(pyridine-2-ylmethyl)amino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 98% (>99% ee) (S)-DTB-SpiroPAP

15-5167 / 25mg
CAS：1415636-82-6
加入洽詢
(R)-(+)-7,7'-Bis[di(3,5-dimethylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (R)-Xyl-SDP

(R)-(+)-7,7'-Bis[di(3,5-dimethylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (R)-Xyl-SDP

15-5168 / 25mg
CAS：917377-75-4
加入洽詢
(R)-(+)-7,7'-Bis[di(3,5-dimethylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (R)-Xyl-SDP

(R)-(+)-7,7'-Bis[di(3,5-dimethylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (R)-Xyl-SDP

15-5168 / 100mg
CAS：917377-75-4
加入洽詢
(S)-(-)-7,7'-Bis[di(3,5-dimethylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (S)-Xyl-SDP

(S)-(-)-7,7'-Bis[di(3,5-dimethylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (S)-Xyl-SDP

15-5169 / 25mg
CAS：528521-89-3
加入洽詢
(S)-(-)-7,7'-Bis[di(3,5-dimethylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (S)-Xyl-SDP

(S)-(-)-7,7'-Bis[di(3,5-dimethylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (S)-Xyl-SDP

15-5169 / 100mg
CAS：528521-89-3
加入洽詢
(R)-(+)-7,7'-Bis(diphenylphosphino)-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (R)-SDP

(R)-(+)-7,7'-Bis(diphenylphosphino)-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (R)-SDP

15-5174 / 25mg
CAS：917377-74-3
加入洽詢
(R)-(+)-7,7'-Bis(diphenylphosphino)-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (R)-SDP

(R)-(+)-7,7'-Bis(diphenylphosphino)-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (R)-SDP

15-5174 / 100mg
CAS：917377-74-3
加入洽詢
(S)-(-)-7,7'-Bis(diphenylphosphino)-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (S)-SDP

(S)-(-)-7,7'-Bis(diphenylphosphino)-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (S)-SDP

15-5175 / 100mg
CAS：528521-86-0
加入洽詢
(S)-(-)-7,7'-Bis(diphenylphosphino)-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (S)-SDP

(S)-(-)-7,7'-Bis(diphenylphosphino)-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (S)-SDP

15-5175 / 25mg
CAS：528521-86-0
加入洽詢
(R)-(+)-7,7'-Bis[di(4-methylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (R)-Tol-SDP

(R)-(+)-7,7'-Bis[di(4-methylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (R)-Tol-SDP

15-5180 / 100mg
CAS：528521-87-1
加入洽詢
(R)-(+)-7,7'-Bis[di(4-methylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (R)-Tol-SDP

(R)-(+)-7,7'-Bis[di(4-methylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (R)-Tol-SDP

15-5180 / 25mg
CAS：528521-87-1
加入洽詢
(S)-(-)-7,7'-Bis[di(4-methylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (S)-Tol-SDP

(S)-(-)-7,7'-Bis[di(4-methylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (S)-Tol-SDP

15-5181 / 25mg
CAS：817176-80-0
加入洽詢
(S)-(-)-7,7'-Bis[di(4-methylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (S)-Tol-SDP

(S)-(-)-7,7'-Bis[di(4-methylphenyl)phosphino]-2,2',3,3'-tetrahydro-1,1'-spirobiindane, min. 97% (S)-Tol-SDP

15-5181 / 100mg
CAS：817176-80-0
加入洽詢
(11aR)-(+)-5,6,10,11,12,13-Hexahydro-5-phenyl-4H-diindeno[7,1-cd:1’,7’-ef]phosphocin, min. 97% (R)-SITCP

(11aR)-(+)-5,6,10,11,12,13-Hexahydro-5-phenyl-4H-diindeno[7,1-cd:1’,7’-ef]phosphocin, min. 97% (R)-SITCP

15-5184 / 100mg
CAS：856407-37-9
加入洽詢
(11aR)-(+)-5,6,10,11,12,13-Hexahydro-5-phenyl-4H-diindeno[7,1-cd:1’,7’-ef]phosphocin, min. 97% (R)-SITCP

(11aR)-(+)-5,6,10,11,12,13-Hexahydro-5-phenyl-4H-diindeno[7,1-cd:1’,7’-ef]phosphocin, min. 97% (R)-SITCP

15-5184 / 25mg
CAS：856407-37-9
加入洽詢
(11aS)-(+)-5,6,10,11,12,13-Hexahydro-5-phenyl-4H-diindeno[7,1-cd:1’,7’-ef]phosphocin, min. 97% (S)-SITCP

(11aS)-(+)-5,6,10,11,12,13-Hexahydro-5-phenyl-4H-diindeno[7,1-cd:1’,7’-ef]phosphocin, min. 97% (S)-SITCP

15-5185 / 100mg
CAS：885701-78-0
加入洽詢
(11aS)-(+)-5,6,10,11,12,13-Hexahydro-5-phenyl-4H-diindeno[7,1-cd:1’,7’-ef]phosphocin, min. 97% (S)-SITCP

(11aS)-(+)-5,6,10,11,12,13-Hexahydro-5-phenyl-4H-diindeno[7,1-cd:1’,7’-ef]phosphocin, min. 97% (S)-SITCP

15-5185 / 25mg
CAS：885701-78-0
加入洽詢
(R)-(+)-7-[4(S)-(Benzyl)oxazol-2-yl]-7'-diphenylphosphino-2,2’,3,3’-tetrahydro-1,1’-spirobiindane, min. 97% (Ra,S)-Ph-Bn-SIPHOX

(R)-(+)-7-[4(S)-(Benzyl)oxazol-2-yl]-7'-diphenylphosphino-2,2’,3,3’-tetrahydro-1,1’-spirobiindane, min. 97% (Ra,S)-Ph-Bn-SIPHOX

15-5186 / 100mg
CAS：2074610-05-0
加入洽詢
(R)-(+)-7-[4(S)-(Benzyl)oxazol-2-yl]-7'-diphenylphosphino-2,2’,3,3’-tetrahydro-1,1’-spirobiindane, min. 97% (Ra,S)-Ph-Bn-SIPHOX

(R)-(+)-7-[4(S)-(Benzyl)oxazol-2-yl]-7'-diphenylphosphino-2,2’,3,3’-tetrahydro-1,1’-spirobiindane, min. 97% (Ra,S)-Ph-Bn-SIPHOX

15-5186 / 25mg
CAS：2074610-05-0
加入洽詢
(S)-(-)-7-[4(S)-(Benzyl)oxazol-2-yl]-7-diphenylphosphino-2,2’,3,3’-tetrahydro-1,1'-spirobiindane, min. 97% (Sa,S)-Ph-Bn-SIPHOX

(S)-(-)-7-[4(S)-(Benzyl)oxazol-2-yl]-7-diphenylphosphino-2,2’,3,3’-tetrahydro-1,1'-spirobiindane, min. 97% (Sa,S)-Ph-Bn-SIPHOX

15-5187 / 25mg
CAS：913829-88-6
加入洽詢
(S)-(-)-7-[4(S)-(Benzyl)oxazol-2-yl]-7-diphenylphosphino-2,2’,3,3’-tetrahydro-1,1'-spirobiindane, min. 97% (Sa,S)-Ph-Bn-SIPHOX

(S)-(-)-7-[4(S)-(Benzyl)oxazol-2-yl]-7-diphenylphosphino-2,2’,3,3’-tetrahydro-1,1'-spirobiindane, min. 97% (Sa,S)-Ph-Bn-SIPHOX

15-5187 / 100mg
CAS：913829-88-6
加入洽詢
(R)-(+)-7’-[4(S)-(Benzyl)oxazol-2-yl]-7-di(3,5-di-t-butylphenyl)phosphino-2,2’,3,3’-tetrahydro-1,1’-spirobiindane, min. 97% (Ra,S)-DTB-Bn-SIPHOX

(R)-(+)-7’-[4(S)-(Benzyl)oxazol-2-yl]-7-di(3,5-di-t-butylphenyl)phosphino-2,2’,3,3’-tetrahydro-1,1’-spirobiindane, min. 97% (Ra,S)-DTB-Bn-SIPHOX

15-5190 / 25mg
加入洽詢
(R)-(+)-7’-[4(S)-(Benzyl)oxazol-2-yl]-7-di(3,5-di-t-butylphenyl)phosphino-2,2’,3,3’-tetrahydro-1,1’-spirobiindane, min. 97% (Ra,S)-DTB-Bn-SIPHOX

(R)-(+)-7’-[4(S)-(Benzyl)oxazol-2-yl]-7-di(3,5-di-t-butylphenyl)phosphino-2,2’,3,3’-tetrahydro-1,1’-spirobiindane, min. 97% (Ra,S)-DTB-Bn-SIPHOX

15-5190 / 100mg
加入洽詢
(S)-(-)-7’-[4(S)-(Benzyl)oxazol-2-yl]-7-di(3,5-di-t-butylphenyl)phosphino-2,2’,3,3’-tetrahydro-1,1’-spirobiindane, min. 97% (Sa,S)-DTB-Bn-SIPHOX

(S)-(-)-7’-[4(S)-(Benzyl)oxazol-2-yl]-7-di(3,5-di-t-butylphenyl)phosphino-2,2’,3,3’-tetrahydro-1,1’-spirobiindane, min. 97% (Sa,S)-DTB-Bn-SIPHOX

15-5191 / 100mg
CAS：1040274-10-9
加入洽詢
(S)-(-)-7’-[4(S)-(Benzyl)oxazol-2-yl]-7-di(3,5-di-t-butylphenyl)phosphino-2,2’,3,3’-tetrahydro-1,1’-spirobiindane, min. 97% (Sa,S)-DTB-Bn-SIPHOX

(S)-(-)-7’-[4(S)-(Benzyl)oxazol-2-yl]-7-di(3,5-di-t-butylphenyl)phosphino-2,2’,3,3’-tetrahydro-1,1’-spirobiindane, min. 97% (Sa,S)-DTB-Bn-SIPHOX

15-5191 / 25mg
CAS：1040274-10-9
加入洽詢
(R)-(+)-2,2',6,6'-Tetramethoxy-4,4'-bis(diphenylphosphino)-3,3'-bipyridine, min. 97% CTH-(R)-P-Phos

(R)-(+)-2,2',6,6'-Tetramethoxy-4,4'-bis(diphenylphosphino)-3,3'-bipyridine, min. 97% CTH-(R)-P-Phos

15-5200 / 100mg
CAS：221012-82-4
加入洽詢
(R)-(+)-2,2',6,6'-Tetramethoxy-4,4'-bis(diphenylphosphino)-3,3'-bipyridine, min. 97% CTH-(R)-P-Phos

(R)-(+)-2,2',6,6'-Tetramethoxy-4,4'-bis(diphenylphosphino)-3,3'-bipyridine, min. 97% CTH-(R)-P-Phos

15-5200 / 500mg
CAS：221012-82-4
加入洽詢
(S)-(-)-2,2',6,6'-Tetramethoxy-4,4'-bis(diphenylphosphino)-3,3'-bipyridine, min. 95% CTH-(S)-P-Phos

(S)-(-)-2,2',6,6'-Tetramethoxy-4,4'-bis(diphenylphosphino)-3,3'-bipyridine, min. 95% CTH-(S)-P-Phos

15-5201 / 100mg
CAS：362524-23-0
加入洽詢
(S)-(-)-2,2',6,6'-Tetramethoxy-4,4'-bis(diphenylphosphino)-3,3'-bipyridine, min. 95% CTH-(S)-P-Phos

(S)-(-)-2,2',6,6'-Tetramethoxy-4,4'-bis(diphenylphosphino)-3,3'-bipyridine, min. 95% CTH-(S)-P-Phos

15-5201 / 500mg
CAS：362524-23-0
加入洽詢
(R)-(+)-2,2',6,6'-Tetramethoxy-4,4'-bis(di(3,5-xylyl)phosphino)-3,3'-bipyridine, min. 97% CTH-(R)-Xylyl-P-PHOS

(R)-(+)-2,2',6,6'-Tetramethoxy-4,4'-bis(di(3,5-xylyl)phosphino)-3,3'-bipyridine, min. 97% CTH-(R)-Xylyl-P-PHOS

15-5210 / 100mg
CAS：442905-33-1
加入洽詢
(R)-(+)-2,2',6,6'-Tetramethoxy-4,4'-bis(di(3,5-xylyl)phosphino)-3,3'-bipyridine, min. 97% CTH-(R)-Xylyl-P-PHOS

(R)-(+)-2,2',6,6'-Tetramethoxy-4,4'-bis(di(3,5-xylyl)phosphino)-3,3'-bipyridine, min. 97% CTH-(R)-Xylyl-P-PHOS

15-5210 / 500mg
CAS：442905-33-1
加入洽詢
(S)-(-)-2,2',6,6'-Tetramethoxy-4,4'-bis(di(3,5-xylyl)phosphino)-3,3'-bipyridine, min. 95% CTH-(S)-Xylyl-P-Phos

(S)-(-)-2,2',6,6'-Tetramethoxy-4,4'-bis(di(3,5-xylyl)phosphino)-3,3'-bipyridine, min. 95% CTH-(S)-Xylyl-P-Phos

15-5211 / 500mg
CAS：443347-10-2
加入洽詢
(S)-(-)-2,2',6,6'-Tetramethoxy-4,4'-bis(di(3,5-xylyl)phosphino)-3,3'-bipyridine, min. 95% CTH-(S)-Xylyl-P-Phos

(S)-(-)-2,2',6,6'-Tetramethoxy-4,4'-bis(di(3,5-xylyl)phosphino)-3,3'-bipyridine, min. 95% CTH-(S)-Xylyl-P-Phos

15-5211 / 100mg
CAS：443347-10-2
加入洽詢
Tetramethylbiphosphine disulfide, 99%

Tetramethylbiphosphine disulfide, 99%

15-5350 / 25g
CAS：3676-97-9
加入洽詢
Tetramethylbiphosphine disulfide, 99%

Tetramethylbiphosphine disulfide, 99%

15-5350 / 5g
CAS：3676-97-9
加入洽詢
1,3,5,7-Tetramethyl-8-phenyl-2,4,6-trioxa-8-phosphaadamantane, 99% MeCgPPh

1,3,5,7-Tetramethyl-8-phenyl-2,4,6-trioxa-8-phosphaadamantane, 99% MeCgPPh

15-5355 / 500mg
CAS：97739-46-3
加入洽詢
1,3,5,7-Tetramethyl-8-phenyl-2,4,6-trioxa-8-phosphaadamantane, 99% MeCgPPh

1,3,5,7-Tetramethyl-8-phenyl-2,4,6-trioxa-8-phosphaadamantane, 99% MeCgPPh

15-5355 / 2g
CAS：97739-46-3
加入洽詢
Tetraphenylphosphonium bromide, 99%

Tetraphenylphosphonium bromide, 99%

15-5450 / 25g
CAS：2751-90-8
加入洽詢
Tetraphenylphosphonium bromide, 99%

Tetraphenylphosphonium bromide, 99%

15-5450 / 100g
CAS：2751-90-8
加入洽詢
Tetraphenylphosphonium bromide, 99%

Tetraphenylphosphonium bromide, 99%

15-5450 / 5g
CAS：2751-90-8
加入洽詢
p-Tolyldiphenylphosphine, min. 96%

p-Tolyldiphenylphosphine, min. 96%

15-5600 / 25g
CAS：1031-93-2
加入洽詢
p-Tolyldiphenylphosphine, min. 96%

p-Tolyldiphenylphosphine, min. 96%

15-5600 / 100g
CAS：1031-93-2
加入洽詢
(11bR)-N-Methyl-N-[(R)-1-phenylethyl]-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, 98%

(11bR)-N-Methyl-N-[(R)-1-phenylethyl]-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, 98%

15-5610 / 50mg
CAS：1021439-57-5
加入洽詢
(11bS)-N,N-Bis[(S)-1-phenylethyl]-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, 98%, (99% ee)

(11bS)-N,N-Bis[(S)-1-phenylethyl]-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, 98%, (99% ee)

15-5614 / 100mg
CAS：209482-27-9
加入洽詢
LOCATIONS

服務據點

北北基/宜蘭/花蓮
  • 北北基/宜蘭/花蓮
  • 桃園
  • 新竹縣/新竹市/苗栗
  • 台中/彰化/南投
  • 雲林/嘉義/台南
  • 高雄/屏東/台東

台北分公司

地址 台北市南港區南港路三段50巷10號5樓
電話 02-2786-2331
傳真 02-2653-6959
郵件 taipei@echochemical.com

桃園分公司

地址 桃園市平鎮區復興街62號2樓
電話 03-494-6939
傳真 03-493-0687
郵件 chungli@echochemical.com

總公司 / 竹苗分公司

地址 苗栗縣頭份市工業路16號
電話 037-621-088
傳真 037-615-096
郵件 miaoli@echochemical.com

台中分公司

地址 台中市南屯區文心路一段218號15F之2
電話 04-2472-8859
傳真 04-2472-8825
郵件 taichung@echochemical.com

台南分公司

地址 台南市永康區鹽洲一街63巷33號
電話 06-243-6589
傳真 06-253-8208
郵件 tainan@echochemical.com

高雄分公司

地址 高雄市鳳山區鳳頂路479號
電話 07-753-9988
傳真 07-753-1958
郵件 kaohsiung@echochemical.com
北北基/宜蘭/花蓮 桃園 新竹縣/新竹市/苗栗 台中/彰化/南投 雲林/嘉義/台南 高雄/屏東/台東
mapNorth
mapTaoyuan
mapHsinchu
mapCentral
mapYunlin
mapSouth
EN
詢價車
洽詢車

你的洽詢車總計 0 件產品

洽詢表單
依據歐盟施行的個人資料保護法，我們致力於保護您的個人資料並提供您對個人資料的掌握。
按一下「全部接受」，代表您允許我們置放 Cookie 來提升您在本網站上的使用體驗、協助我們分析網站效能和使用狀況，以及讓我們投放相關聯的行銷內容。您可以在下方管理 Cookie 設定。 按一下「確認」即代表您同意採用目前的設定。
管理Cookies

隱私權偏好設定中心

依據歐盟施行的個人資料保護法，我們致力於保護您的個人資料並提供您對個人資料的掌握。
按一下「全部接受」，代表您允許我們置放 Cookie 來提升您在本網站上的使用體驗、協助我們分析網站效能和使用狀況，以及讓我們投放相關聯的行銷內容。您可以在下方管理 Cookie 設定。 按一下「確認」即代表您同意採用目前的設定。
查看隱私權政策

管理同意設定

必要的Cookie

一律啟用
網站運行離不開這些 Cookie 且您不能在系統中將其關閉。通常僅根據您所做出的操作（即服務請求）來設置這些 Cookie，如設置隱私偏好、登錄或填充表格。您可以將您的瀏覽器設置為阻止或向您提示這些 Cookie，但可能會導致某些網站功能無法工作。